Finanzen von Adverum Biotechnologies Inc (ADVM)ADVMAdverum Biotechnologies Inc

Evaluating the bottom line, Adverum Biotechnologies Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -417.79%, provide a clear picture of how effectively ADVM converts its operational activities into shareholder value.

In the context of the broader market, ADVM competes directly with industry leaders such as ADAG and CTOR. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, ADVM's gross margin of N/A stands against ADAG's 100.00% and CTOR's 67.07%. Such benchmarking helps identify whether Adverum Biotechnologies Inc is trading at a premium or discount relative to its financial performance.